Projected Growth of the Global Smart Insulin Pens Market to Reach $0.15 Billion by 2029
Uncover key drivers, emerging technologies, and competitive movements shaping the smart insulin pens market from 2025–2034 with trusted insights from The Business Research Company
What CAGR And Valuation Are Anticipated For The Smart Insulin Pens Market By The End Of 2029?
The smart insulin pens market has experienced robust expansion in recent years. Its size is projected to expand from $0.11 billion in 2024 to $0.11 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.1%. Historically, this growth can be linked to factors such as a rise in diabetes prevalence, significant economic advancement in developing markets, an expanding elderly population, increased spending on healthcare, and reforms in public health insurance.
The smart insulin pens market is projected to experience robust expansion in the coming years, with its valuation anticipated to reach $0.15 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 7.0%. This projected growth is driven by factors such as a rising disease burden, proactive government initiatives, and continuous technological advancements. Key trends expected during this period involve collaborations with technology firms, the development of smart insulin delivery devices, the introduction of novel insulin delivery methods, the integration of the Internet of Things, and a rise in merger and acquisition activities.
Access A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3090&type=smp
Which Business Drivers Are Underpinning The Growth Of The Smart Insulin Pens Market?
Insulin pens facilitate the achievement of a more accurate insulin dose compared to using a vial or a syringe. For children who require insulin administration during school hours and for diabetic patients with visual impairments, an exact insulin dose can be pre-set via the dosage dial, aiding in precise delivery at the moment of injection. For instance, the Echo Plus by Novo Nordisk, a pediatric-friendly insulin pen, allows for half-unit dosing, up to a maximum of 30 units. Similarly, Lilly’s HumaPen Luxura HD enables insulin delivery in half-unit increments, and the NovoPen Junior – Insulin Pen by Novo Nordisk can deliver highly accurate insulin doses with fine adjustments for small amounts, even down to half-unit increments. These accurate adjustments and dose delivery capabilities prevent both over-dosing and under-dosing of the medication, which is expected to elevate the demand for smart insulin pens and propel the growth of the smart insulin pens market.
What Are The Principal Segment Types In The Smart Insulin Pens Market?
The smart insulin pensmarket covered in this report is segmented –
1) By Type: First Generation Pens, Second Generation Pens
2) By Usability: Prefilled, Reusable
3) By Application: Type 1 Diabetes, Type 2 Diabetes
4) By End User: Hospitals & Clinics, Ambulatory Surgical Centres, Home Care Settings
Subsegments:
1) By First Generation Pens: Basic Smart Insulin Pens With Standard Features, Simple Connectivity to Mobile Apps for Tracking and Logging Insulin Doses
2) By Second Generation Pens: Advanced Smart Insulin Pens With Enhanced Features, Real-Time Data Sharing With Healthcare Providers and Caregivers, Sophisticated Mobile Applications for Comprehensive Diabetes Management
How Are Industry Trends Steering The Expansion Of The Smart Insulin Pens Market?
Modern smart insulin pens offer functionalities well beyond just storing information. These devices assist in determining tailored doses, monitor glucose levels continuously, and link with smartphone applications to display the collected data. In November 2022, the US pharmaceutical firm, Eli Lilly and Company, unveiled Tempo, its Personalized Diabetes Management Platform. This extensive system, created by Eli Lilly, aims to improve self-management of diabetes for adults living with type 1 and type 2 diabetes. The Tempo Smart Button, a reusable attachment for the Tempo Pen, records and transmits insulin dosing information. Concurrently, the TempoSmart App records these doses and delivers customized educational content and prompts for medication.
Which Companies Are Contributing Significantly To The Smart Insulin Pens Market Growth?
Major companies operating in the smart insulin pens market include Companion Medical, Novo Nordisk A/S, F. Hoffmann-La Roche AG, Emperra GmbH E-Health Technologies, Diamesco Co. Ltd., Digital Medics Pvt Ltd., Bigfoot Biomedical, Diabnext, Insulet Corporation, Jiangsu Delfu Medical Device Co. Ltd., Sanofi India, Becton Dickinson, Biocon Ltd, Mehar healthcare, Johnson & Johnson, Covidien Healthcare, Philips Healthcare India, Shandong WeiGao Group Medical Polymer Company Limited, Yuwell medical equipment & supply Co, Terumo, NIPRO, Olympus Medical Systems, Nihon Koden, Medtronic PLC, Ypsomed Holding AG, Berlin-Chemie AG, Patients Pending Ltd, Dexcom, Insujet, Eli Lilly., Abbott Laboratories, Tandem Diabetes Care, Inc.
Download The Full Report Here:
https://www.thebusinessresearchcompany.com/report/smart-insulin-pens-global-market-report
Which Region Offers The Most Opportunity For Smart Insulin Pens Market Expansion?
North America was the largest region in the smart insulin pens market in 2024. Western Europe was the second largest region in the global smart insulin pens market share. The regions covered in the smart insulin pens market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Get A Report Customized For You Here:
https://www.thebusinessresearchcompany.com/customise?id=3090&type=smp
Browse Through More Reports Similar to the Global Smart Insulin Pens Market 2025, By The Business Research Company
Diabetes Care Devices Market 2025
https://www.thebusinessresearchcompany.com/report/diabetes-care-devices-market
Insulin Pens Syringes Pumps And Injectors Market 2025
https://www.thebusinessresearchcompany.com/report/insulin-pens-syringes-pumps-and-injectors-market
Therapeutic Proteins Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/therapeutic-proteins-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
